Cascadian Therapeutics, Inc. (CASC) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Vincent Gleason Jr, MBA Vincent Gleason Jr, MBA 10/20/2016 3 months $1.25 $4.21 +236.8% 236 Ended
Comments: This stock could be a hidden gem!
sjhawk2 sjhawk2 09/17/2015 3 months $3.62 $2.18 -39.78% 39 Ended
JeffKorenak JeffKorenak 06/26/2015 3 months $3.90 $3.32 -14.87% -14 Ended
Comments: Strong capital position
LeeTombash LeeTombash 05/23/2015 1 week $3.01 $3.42 +13.62% 13 Ended
markkabbash markkabbash 09/12/2014 1 day $2.25 $2.06 -8.44% 8 Ended
itssofluffyimgonnadie itssofluffyimgonnadie 01/07/2014 3 months $1.81 $2.94 +62.43% -62 Ended
Comments: no positive news for PX866 in sight. will go down further
KJames KJames 09/20/2013 3 months $1.83 $1.73 -5.46% -5 Ended
josefh s josefh s 03/06/2012 1 Year $5.08 $2.24 -55.91% -55 Ended
Comments: Industry sector growing or poised for growth
Donald_11 Donald_11 06/21/2011 1 Year $9.10 $4.24 -53.41% -53 Ended
Comments: Upcoming product launch will be successful

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.